Purchase Order 75N95024P00533
Award Date 9/3/24
Potential Completion Date 11/2/24
Potential Value $18K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hicksville, NY 11802, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to BioIVT, LLC for the procurement of various Hepatopac sample well plates, including human, mouse, and stromal plates, as well as maintenance and application media. The total ceiling value of the contract is $27,249.00, with an anticipated 60-day delivery after receipt of order. The purchase order was awarded on a...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Bioivt, LLC for the purchase of cryopreserved hepatocytes. The contract has a ceiling value of $16,179.20 and a completion date of August 16, 2024. Bioivt, LLC is a leading global provider of high-quality biological specimens and value-added services, with experience delivering similar products to federal agencies including the Defense Health Agency, Army Medical Command, National Institutes of Health,...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Bioivt, LLC, a provider of biological specimens and services. The contract is for the delivery of 5 million units of male human cryoplateable hepatocytes, with a ceiling value of $75,000.00 and a period of performance ending on July 30, 2021. Bioivt has previously provided biological materials and services as a prime contractor and subcontractor to...
- This is a federal purchase order contract awarded by the Bureau of Medicine and Surgery, which is part of the U.S. Department of Defense, to Bioivt, LLC on September 30, 2017. The contract is for the delivery of hepatocyte cells and has a ceiling value of $114,972. The contract has a firm fixed price pricing type and an ultimate completion date of October 23, 2017. Bioivt, LLC is a leading provider of biological specimens and has a history of supporting medical research programs across various...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Bioivt, LLC, a leading global provider of biological specimens and services. The contract, valued at $29,960, is for the acquisition of monkey and human (female) cryoplateable hepatocytes. The contract has an ultimate completion date of August 26, 2024. Bioivt, LLC is a prime contractor that has previously provided biological materials such as cryopreserved and cryoplateable hepatocytes, plasma, serum,...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Bioivt, LLC, a leading provider of biological specimens and services. The $183,092 contract is for a Transporter Substrate Assessment Study to support the development of a novel drug candidate. The study will characterize the metabolic profile and interaction potential of the drug candidate, following FDA guidance. This requirement was competitively solicited under the authority of FAR Part 12 and...
- This firm fixed-price purchase order was awarded to Bioivt, LLC by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services. The $18,575 contract is for the delivery of AD HUMAN CSF and has a period of performance through November 8, 2024. Bioivt is a leading global provider of biological specimens and value-added services, and has previously supported medical research programs across various federal agencies through prime...
- This is a $149,940 firm-fixed-price purchase order awarded by the Department of the Army Medical Command to Bioivt, LLC, a leading provider of biological specimens and services. The contract is for the delivery of male rhesus monkey cryoplateable hepatocytes, with a completion date of September 30, 2020. Bioivt has previously provided similar biological materials such as cryopreserved and cryoplateable hepatocytes, plasma, serum, and urine to support medical research programs across federal...
- Bioivt, LLC was awarded a firm fixed price purchase order valued at $14,997 by the National Center for Advancing Translational Sciences within the Department of Health and Human Services. The contract has no set-aside designation. Under the award, Bioivt will assess the inhibition activity of a test article for common human nucleoside transporters, fulfilling the original agency solicitation. The place of performance is in Westbury, New York and all work must be completed by December 19, 2022....
This is a $18,166 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Bioivt, LLC, a for-profit limited liability company, for the delivery of human and mouse hepatopac plates. The contract has a period of performance through November 2, 2024 and was not set aside for any particular business type. Bioivt is a leading global provider of biological specimens and has supported medical research programs across various federal agencies through past prime and subcontract awards. This order appears to be a direct procurement to support NCATS' mission, which involves advancing translational sciences to accelerate the development of new treatments.
Generated 8/31/24, 11:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 8/30/24 |